Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1
Year: 2025
Type: article
Source: Blood Advances
Institutions: Children's Hospital Colorado, University of Colorado Anschutz, University of Florida, University of California, San Francisco, St. Jude Children's Research Hospital, Children's Mercy Hospital, NYU Langone Health, New York University, Children's Hospital of Philadelphia, University of Pennsylvania, Seattle Children's Hospital, University of Washington, Fred Hutch Cancer Center, Seattle Children's Research Institute, Bristol-Myers Squibb (United States), Cincinnati Children's Hospital Medical Center, University of Cincinnati, The Kids Research Institute Australia, The University of Western Australia, Curtin University, Princess Margaret Hospital for Children, Perth Children's Hospital
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,800
OpenAlex ID: W4414465607